Ad26COVS1 [vakcína Janssen proti COVID-19]
topical
1
- Terms
-
Ad26.COV2.S
Ad26COVS1
JNJ 78436735
JNJ-78436735
vakcína proti COVID-19, Johnson & Johnson
-
Ad26.COV2.S
COVID-19 Vaccine Johnson & Johnson
JNJ 78436735
JNJ-78436735
Johnson & Johnson Covid-19 Vaccine
Persistent link
https://www.medvik.cz/link/D000090984
Definition
A viral vector vaccine designed against SARS-CoV-2 developed by Johnson & Johnson. Its vector encodes the SARS-CoV-2 Spike protein.
- DUI
- D000090984 MeSH Browser
- CUI
- M000742885
- History note
- 2022
- Public note
- 2022; AD26COVS1 was indexed under COVID-19 VACCINES 2021
Allowable subheadings
- AD
- administration & dosage
- AE
- adverse effects
- AG
- agonists
- AA
- analogs & derivatives
- AN
- analysis
- AI
- antagonists & inhibitors
- BI
- biosynthesis
- BL
- blood
- CF
- cerebrospinal fluid
- CS
- chemical synthesis
- CH
- chemistry
- CL
- classification
- EC
- economics
- GE
- genetics
- HI
- history
- IM
- immunology
- IP
- isolation & purification
- ME
- metabolism
- PK
- pharmacokinetics
- PD
- pharmacology
- PO
- poisoning
- RE
- radiation effects
- ST
- standards
- SD
- supply & distribution
- TU
- therapeutic use
- TO
- toxicity
- UR
- urine
...
Occurrences in Medvik records